Canadian vaccine scores 100% in initial trial
November 10, 2020
Antibodies produce immune responses in participants
Canadian drug company Medicago said Tuesday it developed a vaccine that stimulates antibody and cellular immune responses against COVID-19 in 100% of trial participants.
The results prompted optimism fro...